Literature DB >> 12829292

Involvement of intestinal inducible nitric oxide synthase (iNOS) in the early stages of murine salmonellosis.

Mónica N Giacomodonato1, Nora B Goren, Daniel O Sordelli, María I Vaccaro, Daniel H Grasso, Alejandro J Ropolo, M Cristina Cerquetti.   

Abstract

Local induction of inducible nitric oxide synthase (iNOS) and apoptosis was examined in the intestine of mice infected with virulent Salmonella enterica serovar Enteritidis 5694 (S. enteritidis) and its attenuated derivative mutant E/1/3. Both, intestinal iNOS mRNA expression and iNOS activity showed a peak at 4 h only in animals receiving the virulent S. enteritidis. Aminoguanidine treatment abrogated intestinal epithelial damage produced by virulent S. enteritidis and diminished apoptosis at the tips of the villi. Unlike the virulent strain, mutant E/1/3 induced massive iNOS expression in Peyer's patches, these findings may be related to its protective capacity. Our results suggest that intestinal iNOS participates in the early response to intestinal infection and that the final effect depends on the nature of the insult.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829292     DOI: 10.1016/S0378-1097(03)00385-9

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  DksA-dependent resistance of Salmonella enterica serovar Typhimurium against the antimicrobial activity of inducible nitric oxide synthase.

Authors:  Calvin A Henard; Andrés Vázquez-Torres
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

2.  Salmonella typhimurium infection in the porcine intestine: evidence for caspase-3-dependent and -independent programmed cell death.

Authors:  Kirsten Schauser; John Elmerdahl Olsen; Lars-Inge Larsson
Journal:  Histochem Cell Biol       Date:  2004-12-18       Impact factor: 4.304

3.  Nitric oxide and salmonella pathogenesis.

Authors:  Calvin A Henard; Andrés Vázquez-Torres
Journal:  Front Microbiol       Date:  2011-04-20       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.